8-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-a]pyrazine

Catalog No.: 
ACIKPH326
CAS No.: 
140911-01-9
Molecular Formula: 
C8H7ClN4
Molecular Weight: 
194.63
8-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-a]pyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$255.00InquiryInquiry
100mg95%$373.00InquiryInquiry
250mg95%$523.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-a]pyrazine
IUPAC Name8-chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-a]pyrazine
MDL No.MFCD20303912
Molecular FormulaC8H7ClN4
Molecular Weight194.63
SMILESClC1=NC=CN2C1=NN=C2C3CC3
InChI KeyNZCRFSFETSJITG-UHFFFAOYSA-N
Synonym8-chloro-3-cyclopropyl-[1;8-CHLORO-3-CYCLOPROPYL-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE;1,2,4-Triazolo[4,3-a]pyrazine, 8-chloro-3-cyclopropyl-
CAS No.140911-01-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIKPH326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQADO954 route compound structure diagram
    ACQADO95463286-28-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIKPH326 route product structure diagram
    ACIKPH326140911-01-9
Inquiry

2. ACIKPH326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIKPH326 route product structure diagram
    ACIKPH326140911-01-9
Inquiry

3. ACIKPH326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIKPH326 route product structure diagram
    ACIKPH326140911-01-9
Inquiry

Comments (0)